DIPLOMA PLC (DPLM) — Investment Research Note

Executive summary

Diploma is a decentralised, value-add specialist distributor operating across three sectors (Controls, Seals, Life Sciences) that has transformed itself over five years into a genuine quality compounder, growing adjusted EPS at ~26% p.a. through a combination of high-teens organic growth and disciplined bolt-on M&A. Operating momentum has accelerated sharply since FY24, with adjusted operating margins now guided to 26.5% for FY26 (up from ~19% in FY23), organic growth running at 15% YTD, and consensus operating profit upgrades in every trading update for the last two years. The single most important valuation point today is that ~three-quarters of the compounding thesis is now priced in — the stock trades at ~29-30x forward earnings, so the current entry point requires continued near-flawless execution to earn a positive return.

Fair value estimate

• Methodology: Forward P/E, sense-checked against the 5-year compounding track record and quality-distributor peer group (Halma, Bunzl, Rentokil).
• Assumptions: FY26 adjusted operating profit £454m (consensus, referenced in 2026-07-16 Q3 update); ~£25m net interest, 24% tax → FY26 adj EPS ~245-250p on 134.1m shares. Peer group trades at 24-30x forward earnings; Diploma warrants the upper end given its 300bps YoY margin expansion, 15% organic growth, and consistent track record.
• Fair value range: 6,000p – 7,500p per share (25-30x forward earnings on ~250p FY26E adj EPS).
• Implied market cap range: £8,050m – £10,060m (mid £9,050m).
• Compared to current market cap of £9,118m and price of 7,155p, the shares are trading in line with fair value (approximately 0% to -6% downside on the midpoint, +5% upside at the top of the range).

Sector context

Confirmed as Industrial Goods and Services, specifically specialist industrial distribution. On quality metrics (26.5% operating margin, 22.7% ROATCE, 0.8x net debt/EBITDA, 76%+ cash conversion), Diploma sits meaningfully above typical industrial distribution peers and is closer to the quality compounder cohort. Growth is significantly above sector average (15% organic vs peers typically low single digits). Closest listed peers: Halma (HLMA), Bunzl (BNZL), and to a lesser extent RS Group (RS1).

Investment thesis

1. Genuine AI-adjacent exposure via Windy City Wire and Controls sector: WCW is explicitly benefiting from datacentre buildout in the US (low-voltage wire, distributed antenna systems), with H1 FY26 Controls organic growth of 26% and management calling out "attractive end market exposures including aerospace, defence, datacentres, and energy" 2026-05-19 half-year. This is not press-release AI — it is measurable, sustained double-digit growth in the AI-adjacent value chain.
2. Demonstrable operating leverage in action: FY26 revenue guidance implies ~20% reported growth translating into ~42% operating profit growth (2:1 leverage), with margin expanding from 22.5% (Jan 2026 guidance) to 26.5% (July 2026 guidance) in six months 2026-07-16 Q3 update. Value-add pricing power is real.
3. Fortress balance sheet and disciplined capital allocation: Leverage at 0.8x, ROATCE 22.7%, and a proven playbook of tuck-in M&A at ~7-9x EBIT delivering 15-20% year-one ROATCE (CDM defence interconnect completed June 2026, R&G, DICSA, Peerless, TIE) 2026-05-19 half-year. Downside protection is high.

Key risks

1. Priced for continued perfection: At ~29-30x forward earnings, any moderation in organic growth or margin (e.g. back to the 17-19% "financial model" that was standard as recently as FY23) would drive material multiple compression. The 300bps margin surge in H1 FY26 2026-05-19 half-year is impressive but sets a demanding comparator base.
2. Cyclicality of industrial end markets: Despite management's "resilient" framing, Seals, Controls (ex-datacentre), and industrial fasteners are cyclical. The Seals sector saw customer destocking through FY24 2024-05-13 half-year; a broader industrial downturn would test the value-add margin thesis.
3. M&A dependence and pipeline risk: A meaningful portion of forward growth relies on continued acquisitions at attractive multiples (£310m LTM at 8x avg per H1 FY26). If the pipeline slows or multiples rise, forward returns compress. Also, shareholders rejected the additional pre-emption rights disapplication at the January 2026 AGM (resolution 17 failed with 27.4% against) 2026-01-14 AGM result — a mild governance signal that some holders are concerned about equity issuance for M&A.

Operating leverage

The evidence in the filings is strong: H1 FY26 revenue grew 17% while adjusted operating profit grew 33%, with margin expanding 300bps to 24.5% 2026-05-19 half-year. FY26 guidance implies ~20% revenue growth translating to ~42% operating profit growth — a ~2:1 profit-to-revenue leverage ratio. Windy City Wire in particular has doubled operating profit in two years of ownership on a well-invested fixed-cost platform 2023-11-20 full year. That said, this is not "pure software" leverage — Diploma is a value-add distributor with meaningful variable costs (inventory, freight, sales resource), and the recent surge in margin partly reflects a favourable operating environment (aerospace recovery, datacentre boom, US infrastructure spending). Incremental 10-20% revenue upside from here would plausibly deliver ~30-50% operating profit uplift, but this is well-anchored on already-elevated expectations. Not a hyper-leveraged operating model, but genuinely above the typical industrial distributor.

Value-trap signals

None identified. Growth is accelerating not decelerating; balance sheet is strong; cash conversion is healthy; no dividend cuts (5% CAGR); no guidance misses; no related-party concerns; auditor unqualified.

Earnings vs expectations

Pattern is one of consistent beats and upgrades. In the last two years alone: Jan 2026 guidance of 6% organic → May 2026 upgraded to 12% → July 2026 upgraded to 14%; FY26 margin guidance c.22.5% → 25% → 26.5%; FY26 consensus operating profit received a 6% upgrade in May and a further 7% upgrade in July. Similarly, FY24 was upgraded from 11% to 16% reported growth mid-year 2024-05-13 half-year, and FY25 organic growth guidance rose from 6% to 8% to 10% 2025-07-17 Q3 update. Overall summary: a highly reliable beat-and-raise track record for at least three financial years, with management appearing conservative at the start of each year and consistently raising as trading unfolds.

Conviction

4 — high. The financial disclosure is clean, the operating trajectory is well documented across quarterly updates, and multiple valuation methods (forward P/E, peer multiples, DCF implied by 5-year compounding) converge on a similar range. Anchoring factors: (a) 5-year consistent EPS compounding at 26% p.a., (b) explicit consensus operating profit reference in the filings (£454m for FY26), (c) H1 FY26 detailed segmental disclosure allowing near-term forecasting. Limiting factors: (a) the recent 300bps margin surge is unusual and sustainability at 26.5%+ is genuinely uncertain (peers earn less), (b) forward valuation is highly sensitive to whether one applies a 25x or 30x multiple, giving a wide range even on shared assumptions.